Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with hypogonadotropic hypogonadism (a condition where the body does not produce enough sex hormones due to problems with signalling from the brain)
- People diagnosed with Kallmann syndrome (a condition that delays or prevents puberty and affects the sense of smell)
- People diagnosed with adult-onset hypogonadotropic hypogonadism (the same type of hormone signalling problem that develops in adulthood)
- People diagnosed with hypothalamic amenorrhea (absent periods caused by a problem in a part of the brain called the hypothalamus)
- People diagnosed with polycystic ovarian syndrome (PCOS)
- People diagnosed with primary gonadal failure (where the reproductive organs do not work properly)
- People diagnosed with precocious puberty (puberty that begins unusually early)
- People diagnosed with cleft lip or cleft palate
- Family members of people in any of the groups listed above
Who may not be able to join:
- People who are currently seriously ill or hospitalised
- People who have a tumour on the pituitary gland (a small gland at the base of the brain)
- People with iron overload, also known as hemochromatosis (a condition where too much iron builds up in the body)
- People with certain diseases that cause inflammation in organs, such as sarcoidosis (confirm with trial site)
- People with a history of long-term heavy alcohol use
- People who use illicit (illegal) drugs
- People who misuse anabolic steroids (substances sometimes used to build muscle)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nelly Pitteloud, M.D., Centre Hositalier Universitaire Vaudois (CHUV)
Phone: +41 79 556 60 13
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
rare sequence variant(s) in gene(s)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.